Clinical Trials Logo

Coronary Artery Disease clinical trials

View clinical trials related to Coronary Artery Disease.

Filter by:

NCT ID: NCT02504307 Completed - Clinical trials for Coronary Artery Disease

OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation

Laranjeiras
Start date: July 2015
Phase: Phase 4
Study type: Interventional

Prospective, single center, randomized and non-inferiority study, to include up to 60 patients with de novo coronary artery disease. Patients will be followed at 30 days, 3, 6 and 12 months. At 3 months all patients will be submitted to angiographic and OCT evaluation.

NCT ID: NCT02502851 Completed - Clinical trials for Coronary Atherosclerosis Due to Severely Calcified Coronary Lesion

The Comparison of Strategies to PREPARE Severely CALCified Coronary Lesions Trial (PREPARE-CALC)

PREPARE-CALC
Start date: September 2014
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the success of lesion preparation with either rotational atherectomy or cutting/scoring balloons as well as the long term effects of a hybrid sirolimus-eluting stent in an angiographically well-defined group of patients with complex calcified coronary lesions.

NCT ID: NCT02499679 Completed - Clinical trials for Coronary Artery Disease

Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care

ADVANCE
Start date: July 2015
Phase:
Study type: Observational [Patient Registry]

The objective of the HeartFlow ADVANCE Registry is to evaluate utility, clinical outcomes and resource utilization of FFRCT-guided evaluation in clinically stable, symptomatic patients with coronary artery disease (CAD) in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in the diagnosis and management of CAD.

NCT ID: NCT02499445 Completed - Clinical trials for Ischemic Heart Disease

Myocardial Injury in Remifentanil-based Versus Sevoflurane-sufentanil Balanced Regimens in OPCAB Surgery

Start date: November 2007
Phase: N/A
Study type: Interventional

In patients undergoing off-pump coronary artery bypass (OPCAB) surgery with different anesthesia regimens: remifentanil (0.75 mcg/kg/min) and propofol (TCI effect-site concentration 0.8-1.5 mcg/ml) (Group -RP); remifentanil (0.75 mcg/kg/min) and sevoflurane (end-tidal 0.8 vol%) (Group-RS), or sevoflurane (end-tidal 1.2-2.8 vol%)-sufentanil (TCI effect site concentration 0.35-0.75 ng/ml) (Group-SS), intergroup difference in the level of Troponin I (c-TnI) and creatinine kinase subtype-MB is determined before surgery (control), during vascular graft harvesting (harvesting), after completing graft construction (postgrafting), and one day after surgery (postoperative).

NCT ID: NCT02498431 Completed - Clinical trials for Coronary Artery Disease

Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention

IRICARDIO
Start date: June 2015
Phase: N/A
Study type: Interventional

The investigators aim to evaluate circulating irisin levels alterations in patients with acute myocardial infraction and in patients with coronary artery disease subjected to percutaneous coronary intervention.

NCT ID: NCT02496234 Completed - Clinical trials for Coronary Artery Disease

The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery

Start date: July 2015
Phase: N/A
Study type: Observational

Cardiac surgery associated acute kidney injury (CSA-AKI) has been recognized as the second most common cause of hospital acquired AKI. The development of CSA-AKI is independently associated with an increased risk of in-hospital death. There are currently no biomarkers that could identify patients at higher risk for AKI and current risk predictor scores that are based on clinical and demographic information are inadequate. Therefore, a diagnostic test for predicting AKI risk in this clinical context would assist clinicians to optimize surgical strategy and postoperative care to prevent CSA-AKI occurrence and improve patient outcomes. The primary purpose of this study is to measure the association between baseline expression of senescence markers in blood using SenesceTest and the occurrence of CSA-AKI post surgery.

NCT ID: NCT02494947 Completed - Coronary Disease Clinical Trials

Coronary Disease and the Effect of High-intensity Interval Training

CENIT
Start date: February 2016
Phase: N/A
Study type: Interventional

The primary purpose of this study is to investigate if systematic, high intensity, interval-based aerobic exercise training results in regression of lipid content of atherosclerotic coronary artery plaques, and in reduction of plaque burden in patients with stable coronary heart disease. Composition and morphologic characteristics of plaques will be studied by intra-coronary near-infrared spectroscopy (NIRS) and intravascular ultrasound (IVUS) in patients undergoing percutaneous coronary intervention.

NCT ID: NCT02494557 Completed - Clinical trials for Coronary Arteriosclerosis

Risk Stratification for Coronary Artery Disease With Type 2 Diabetic Patients

CAD-risk
Start date: September 2014
Phase: N/A
Study type: Observational

Diabetic type 2 patients (DB2) has a higher prevalence of coronary artery disease (CAD) than non-diabetic persons. Presence of CAD results in murmurs arising from the filling of the arteries and can be detected by the CADScor System and can together with biological patient profile indicate the risk of presence of CAD in the patient. In the pilot study 100 asymptomatic DB2-patients examined with CADScor System and biomarkers will be compared with computed tomography (CT) cardiography and single-photon emission computed tomography (SPECT) for assessing if combination of patient profile (gender, age etc) combined with above measures may give rise to new improved risk scoring method for he DB2-patient.

NCT ID: NCT02493413 Completed - Obesity Clinical Trials

The Stress-release Effects of Exercise in Obese Are Determined by DS14 Score and T-cell Activation Status

Start date: January 2012
Phase: N/A
Study type: Observational

The purpose of the study was to analyze negative affectivity (NA) and social inhibition (SI) inquired by DS14 score in type D personality (distressed personality) to the relation of autonomic regulation of heart function (HRV) and immune response (T lymphocyte) among obese patients within coronary heart disease group (CHD). As stress is the key psychological activator of the hypothalamic-pituitary-adrenal axis (HPA axis) and therefore an important risk factor for diminished immune competency and prevalence of chronic conditions such as obesity, investigators chose exercise as the stress release intervention, especially as chronic stress may have a role in obesity, related to initiation or exacerbation of the condition. Abnormal regulation of the hypothalamic-pituitary-adrenal axis is additionally associated with chronic inflammatory conditions. Proinflammatory T-lymphocytes are present in visceral adipose tissue and may contribute to local inflammatory cell activation before the appearance of macrophages, suggesting that these cells could play an important role in the initiation and perpetuation of adipose tissue inflammation.

NCT ID: NCT02493205 Completed - Clinical trials for Coronary Artery Disease

The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial

HALT
Start date: June 2015
Phase:
Study type: Observational

The Holding Area LINQ Trial is a clinical trial designed to compare the benefits in conducting impant procedures in the holding area of a hospital operating room vs cardiac catheterization/electrophysiology laboratory.